The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Peptides Might Be Making a Comeback In 2023, the FDA restricted 19 peptides from compounding pharmacies. Now, regulators are reviewing a possible reversal, which could allow 14 of those peptides to Orthopedic Use of BPC 157 Sports Med Review FDA July 2026 Peptide Meeting: What Patients Need to Know About Access, Approval, and Safety Meto blog Is BPC 157 Banned? Oral vs. Injectable Forms Explained Is BPC 157 FDA approved? Latest News 2026